WallStreetZenWallStreetZen

NASDAQ: PROK
Prokidney Corp Stock Forecast, Predictions & Price Target

Analyst price target for PROK

Based on 3 analysts offering 12 month price targets for Prokidney Corp.
Min Forecast
$3.00+0.33%
Avg Forecast
$4.33+44.92%
Max Forecast
$6.00+100.67%

Should I buy or sell PROK stock?

Based on 3 analysts offering ratings for Prokidney Corp.
Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PROK stock forecasts and price targets.

PROK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-10
lockedlocked$00.00+00.00%2024-05-29
lockedlocked$00.00+00.00%2024-03-07

1 of 1

Forecast return on equity

Is PROK forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is PROK forecast to generate an efficient return on assets?
Company
-39.44%
Industry
27.66%
PROK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PROK earnings per share forecast

What is PROK's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.61
Avg 2 year Forecast
-$0.72
Avg 3 year Forecast
-$0.66

PROK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PROK$2.99$4.33+44.92%Buy
ZNTL$9.79$29.00+196.22%Buy
PRAX$41.09$105.80+157.48%Buy
PLRX$11.76$42.20+258.84%Buy
CRGX$17.10$32.00+87.13%Strong Buy

Prokidney Stock Forecast FAQ

Is Prokidney Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PROK) stock is to Buy PROK stock.

Out of 3 analysts, 1 (33.33%) are recommending PROK as a Strong Buy, 0 (0%) are recommending PROK as a Buy, 2 (66.67%) are recommending PROK as a Hold, 0 (0%) are recommending PROK as a Sell, and 0 (0%) are recommending PROK as a Strong Sell.

If you're new to stock investing, here's how to buy Prokidney stock.

What is PROK's earnings growth forecast for 2024-2026?

(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.14%.

Prokidney's earnings in 2024 is -$35,295,000.On average, 3 Wall Street analysts forecast PROK's earnings for 2024 to be -$141,335,804, with the lowest PROK earnings forecast at -$159,871,647, and the highest PROK earnings forecast at -$111,215,059. On average, 2 Wall Street analysts forecast PROK's earnings for 2025 to be -$165,664,098, with the lowest PROK earnings forecast at -$169,139,568, and the highest PROK earnings forecast at -$162,188,627.

In 2026, PROK is forecast to generate -$152,920,706 in earnings, with the lowest earnings forecast at -$152,920,706 and the highest earnings forecast at -$152,920,706.

What is PROK's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: PROK) forecast ROE is N/A, which is considered weak.

What is PROK's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PROK price target, the average PROK price target is $4.33, with the highest PROK stock price forecast at $6.00 and the lowest PROK stock price forecast at $3.00.

On average, Wall Street analysts predict that Prokidney's share price could reach $4.33 by Jun 10, 2025. The average Prokidney stock price prediction forecasts a potential upside of 44.92% from the current PROK share price of $2.99.

What is PROK's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: PROK) Prokidney's current Earnings Per Share (EPS) is -$0.57. On average, analysts forecast that PROK's EPS will be -$0.61 for 2024, with the lowest EPS forecast at -$0.69, and the highest EPS forecast at -$0.48. On average, analysts forecast that PROK's EPS will be -$0.72 for 2025, with the lowest EPS forecast at -$0.73, and the highest EPS forecast at -$0.70. In 2026, PROK's EPS is forecast to hit -$0.66 (min: -$0.66, max: -$0.66).

What is PROK's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: PROK) forecast ROA is -39.44%, which is lower than the forecast US Biotechnology industry average of 27.66%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.